TOP
|
Salcoat Capsule for Oral Spra 100¡Á50¦Ìg(¶þ±ûËᱶÂÈÃ×ËÉ¿ÚÇ»ÅçÎíÓýºÄÒ)
|
|
|
|
Ò©µê¹ú±ð£º |
|
²úµØ¹ú¼Ò£º | ÈÕ±¾ |
´¦ ·½ Ò©£º | ÊÇ |
ËùÊôÀà±ð£º | 50΢¿Ë/½ºÄÒ 100½ºÄÒ/ºÐ |
°ü×°¹æ¸ñ£º |
50΢¿Ë/½ºÄÒ 100½ºÄÒ/ºÐ |
¼Æ¼Ûµ¥Î»£º |
ºÐ |
Éú²ú³§¼ÒÖÐÎIJο¼ÒëÃû: |
µÛÈËÖÆÒ© |
Éú²ú³§¼ÒÓ¢ÎÄÃû: |
Teijin Pharma Limited |
¸ÃÒ©Æ·Ïà¹ØÐÅÏ¢ÍøÖ·1: |
|
¸ÃÒ©Æ·Ïà¹ØÐÅÏ¢ÍøÖ·2: |
|
¸ÃÒ©Æ·Ïà¹ØÐÅÏ¢ÍøÖ·3: |
|
|
Ô²úµØÓ¢ÎÄÉÌÆ·Ãû: |
Salcoat£¨¥µ¥ë¥³©`¥È¥«¥×¥»¥ëÍâÓã©50¦Ìg/Capsule 100Capsule/box |
Ô²úµØÓ¢ÎÄÒ©Æ·Ãû: |
Beclometasone Dipropionate |
ÖÐÎIJο¼ÉÌÆ·ÒëÃû: |
Salcoat£¨¥µ¥ë¥³©`¥È¥«¥×¥»¥ëÍâÓã©50΢¿Ë/½ºÄÒ 100½ºÄÒ/ºÐ |
ÖÐÎIJο¼Ò©Æ·ÒëÃû: |
¶þ±ûËᱶÂÈÃ×ËÉ |
ÔøÓÃÃû: |
|
|
|
¼ò½é£º
²¿·ÝÖÐÎĶþ±ûËᱶÂÈÃ×ËÉ´¦·½×ÊÁÏ£¨½ö¹©²Î¿¼£©
ÉÌÆ·Ãû£ºSalcoat Capsule for Oral Spra
Ó¢ÎÄÃû£ºBeclometasone Dipropionate
ÖÐÎÄÃû£º¶þ±ûËᱶÂÈÃ×ËÉ¿ÚÇ»ÅçÎíÓýºÄÒ
Éú²úÉÌ£ºµÛÈËÖÆÒ©
Ò©Æ·¼ò½é
Salcoat£¨¥µ¥ë¥³©`¥È¥«¥×¥»¥ëÍâÓÃ,Beclometasone Dipropionate,¶þ±ûËᱶÂÈÃ×ËÉ£©¿ÚÇ»ÅçÎíÓýºÄÒÊÇÒ»ÖÖ¿ÚÇ»À£ÑñÖÎÁƼÁ£¬ÁÙ´²ÎªµÚÒ»¿îÓÃÓÚ°éÓÐÃÓÀûòÀ£ÑñµÄÄÑÖÎÐÔ¿ÚÇ»Ñ×µÄÖÎÁÆÐÂÒ©¡£
¥µ¥ë¥³©`¥È¥«¥×¥»¥ëÍâÓÃ50μg
ҩЧ·ÖÀàÃû³Æ
ÅçÎíÐÍ¿ÚÇ»À£ÑñÖÎÁƼÁ
Åú×¼ÈÕÆÚ£º1987Äê4ÔÂ
É̘ËÃû
Salcoat Capsule for Oral Spray
Ò»°ãµÄÃû³Æ
¥Ù¥¯¥í¥á¥¿¥¾¥ó¥×¥í¥Ô¥ª¥óËᥨ¥¹¥Æ¥ë
£¨Beclometasone Dipropionate£©
»¯Ñ§Ãû
9-Chloro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione 17,21-dipropanoate
·Ö×Óʽ
C28H37ClO7
·Ö×ÓÁ¿
521.04
ÐÔ×´
Ϊ°×É«ÖÁ΢»ÆÉ«·ÛÄ©£¬ÎÞ³ô¡£Ò×ÈÜÓÚÂȷ£¬Î¢ÈÜÓÚ¼×´¼£¬Î¢ÈÜÓÚÒÒ´¼£¨95£©»ò1,4-¶þ¶ñÍ飬΢ÈÜÓÚÒÒÃÑ£¬¼¸ºõ²»ÈÜÓÚË®¡£
»¯Ñ§˜‹Ôìʽ
ÈÛµã
Ô¼208¡æ£¨·Ö½â£©
´¦Àí×¢ÒâÊÂÏî
±£´æ·½·¨
ÓÉÓÚÊÒÄÚ¹âÏßÉ¢É䣬½ºÄÒµÄÑÕÉ«¿ÉÄÜ»áÂÔÓÐÍÊÉ«£¬µ«²»Ó°ÏìÄÚÈÝÎï¡£
ҩЧҩÀí
×÷ÓûúÖÆ
ÓÉÓÚÖ÷Òª³É·Ö±ûËᱶÂÈÃ×ËɵĿ¹Ñ××÷Ó㬸ÃÒ©ÎïÕ³¸½²¢¾Ö²¿Í£ÁôÔÚ¿ÚǻճĤÉϲ¢·¢»ÓÆä×÷Óá£
Ö÷ÒªÒ©Îï±ûËᱶÂÈÃ×ËɵÄҩЧ
ÔÚÈËÌåƤ·ôѪ¹ÜÊÕËõÊÔÑéÖУ¬±ûËᱶÂÈÃ×Ëɵľֲ¿¿¹Ñ××÷ÓÃÊÇÇú°²ÄεµÄ5±¶£¬ÊǵØÈûÃ×ËɵÄ600±¶¡£
»ù´¡ÊôÐÔ
¸ÃÒ©ÎïµÄ»ùÖÊÓÉÒÔôDZû»ùÏËάËØΪÖ÷Òª³É·ÖµÄ¾ÛºÏÎï»ùÖÊ×é³É£¬¶Ô¿ÚÇ»µÈð¤Ä¤¾ßÓиßÕ³¸½Á¦£¬²¢ËæÍÙÒºÅòÕÍÐγÉÈáÈ͵ı¡²ã£¬¸²¸Ç»¼´¦²¡±ä¡£±£»¤£¨¸²¸ÇÊÜÓ°ÏìµÄÇøÓò£©²¢¼õÇá½Ó´¥Í´¡£¶øÇÒ²»Ò×ÒòÎïÀíĦ²Á¶ø·ÖÀ루´´ÃæÕ³Á¬£©£¬¾ßÓÐÖð½¥Èܽâ¾Ö²¿Õ³¸½ºÍ¾Ö²¿³¤Ê±¼äÍ£Áô£¨¾Ö²¿»ºÊÍ£©µÄÌØÐÔ¡£
ÊÊÓ¦Ö¢
°éÓÐÃÓÀûòÀ£ÑñµÄÄÑÖÎÐÔ¿ÚÇ»Ñ×
Ó÷¨ÓëÓÃÁ¿
ͨ³££¬Ê¹ÓÃÌØÊâµÄСÅçÎíÆ÷ÿÌì2-3´Î½«1Á£½ºÄÒ£¨50μg±ûËᱶÂÈÃ×ËÉ£©¾ùÔÈÅçÈ÷ÔÚ»¼´¦¡£¿É¸ù¾Ý»¼ÕßµÄÖ¢×´µ÷Õû¼ÁÁ¿¡£
ÁÙ´²½á¹û
¹¦Ð§ºÍ°²È«ÐÔ²âÊÔ
¹úÄÚÁÙ´²ÊÔÑé
½ØÖÁÅú׼ʱ£¬ÔÚÈÕ±¾42¼ÒÉèÊ©¹²325Ãû»¼ÕßÖнøÐеİüÀ¨¿ÚÇ»ÃÓÀûòÀ£ÑñµÄ±È½ÏÁÙ´²Ñо¿ÔÚÄÚµÄÁÙ´²Ñо¿ÖУ¬ÌÛÍ´¡¢´óС¡¢·¢ºìµÈµÄÓÐЧָÊý³¬¹ýÁËÓÐЧָ±ê¡£Ð§ÂÊΪ71.2%(205/288)¡£
°ü×°
PTP£º100Á££¨10 Á£x10£©
±£´æ·½Ê½/ÓÐЧÆÚ
±£´æ·½·¨
ÔÚÊÒÎÂÏ´¢´æ
ÓÐЧÆÚ
3Äê
ÖÆÔìÉ̺ͷÖÏúÉÌ
µÛÈËÖÆÒ©ÓÐÏÞ¹«Ë¾
×¢£ºÒÔÉÏÖÐÎIJ»¹»ÍêÕû£¬Ê¹ÓÃÕßÒÔÔ´¦·½×ÊÁÏΪ׼¡£
ÍêÕû˵Ã÷×ÊÁϸ½¼þ£º
https://www.info.pmda.go.jp/go/pack/2399708A1039_1_02/?view=frame&style=XML&lang=ja |
|
|
¡¾´ó ÖРС¡¿¡¾´òÓ¡¡¿
¡¾·±Ìå¡¿¡¾Í¶¸å¡¿¡¾Êղء¿
¡¾ÍƼö¡¿¡¾¾Ù±¨¡¿¡¾ÆÀÂÛ¡¿
¡¾¹Ø±Õ¡¿ ¡¾·µ»Ø¶¥²¿¡¿ |
|
ÉÏһƪ£ºSalcoat Capsule Oral Spray 50¦Ì.. |
ÏÂһƪ£ºOtezla Comprimidos recubiertos.. |
|